Retrovesical Hybrid Benign Peripheral Nerve Sheath Tumor with a Heterozygous Germline NF2 Deletion in a 12-Year-Old Boy: A Case Report.

Authors

Mehmet Can, Ayşe Gül Tavukçu Tantay, Tolga Yüksel, Özkan Okur, Filiz Hazan, Durdugül Ayyıldız Emecen

Published in

Fetal and pediatric pathology. Pages 1-10. Aug 20, 2026. Epub Aug 20, 2026.

Abstract

Background: Hybrid benign peripheral nerve sheath tumors (BPNSTs) combine schwannomatous, neurofibromatous, and/or perineuriomatous components and are frequently associated with NF2-related schwannomatosis. Pediatric cases at retrovesical sites have not previously been reported. Case report: A 12-year-old boy presented with one-year voiding difficulty. Pelvic magnetic resonance imaging showed an indeterminate 27 × 33 mm retrovesical lesion in the seminal vesicle region. Laparoscopic excision yielded a solid mass composed of distinct schwannomatous and neurofibromatous components. The schwannomatous areas were strongly S-100 positive and CD34 negative, whereas the neurofibromatous areas showed patchy S-100 and diffuse CD34 positivity; factor XIIIa was more extensive in the neurofibromatous component. Ki-67 was 3%, without necrosis or mitoses. Multiplex ligation-dependent probe amplification identified a heterozygous germline NF2 deletion (upstream-exon 9). At 6 months, the patient was symptom-free without recurrence. Conclusion: Hybrid BPNST should be considered in pediatric indeterminate retrovesical masses; integrated histopathologic, immunohistochemical, and molecular analysis-including germline NF2-guides diagnosis and long-term surveillance.

PMID:
42623304
Bibliographic data and abstract were imported from PubMed on 21 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.